These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14711812)

  • 1. Dual mechanisms for shedding of the cellular prion protein.
    Parkin ET; Watt NT; Turner AJ; Hooper NM
    J Biol Chem; 2004 Mar; 279(12):11170-8. PubMed ID: 14711812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ectodomain shedding of angiotensin-converting enzyme is independent of its localisation in lipid rafts.
    Parkin ET; Tan F; Skidgel RA; Turner AJ; Hooper NM
    J Cell Sci; 2003 Aug; 116(Pt 15):3079-87. PubMed ID: 12799421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
    Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
    J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform.
    Baron GS; Caughey B
    J Biol Chem; 2003 Apr; 278(17):14883-92. PubMed ID: 12594216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the tail wag the dog? How the structure of a glycosylphosphatidylinositol anchor affects prion formation.
    Bate C; Nolan W; Williams A
    Prion; 2016 Mar; 10(2):127-30. PubMed ID: 26901126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+ cells from paroxysmal nocturnal hemoglobinuria (PNH) patients are deficient in surface expression of cellular prion protein (PrPc).
    Risitano AM; Holada K; Chen G; Simak J; Vostal JG; Young NS; Maciejewski JP
    Exp Hematol; 2003 Jan; 31(1):65-72. PubMed ID: 12543108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GPI-anchoring of PrP: implications in sorting and pathogenesis.
    Puig B; Altmeppen H; Glatzel M
    Prion; 2014; 8(1):11-8. PubMed ID: 24509692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separate mechanisms act concurrently to shed and release the prion protein from the cell.
    Wik L; Klingeborn M; Willander H; Linne T
    Prion; 2012; 6(5):498-509. PubMed ID: 23093798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-glycans and glycosylphosphatidylinositol-anchor act on polarized sorting of mouse PrP(C) in Madin-Darby canine kidney cells.
    Puig B; Altmeppen HC; Thurm D; Geissen M; Conrad C; Braulke T; Glatzel M
    PLoS One; 2011; 6(9):e24624. PubMed ID: 21931781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular transfer of the cellular prion protein.
    Liu T; Li R; Pan T; Liu D; Petersen RB; Wong BS; Gambetti P; Sy MS
    J Biol Chem; 2002 Dec; 277(49):47671-8. PubMed ID: 12359724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.
    Bate C; Nolan W; Williams A
    J Biol Chem; 2016 Jan; 291(1):160-70. PubMed ID: 26553874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylphosphatidylinositol Anchor Modification Machinery Deficiency Is Responsible for the Formation of Pro-Prion Protein (PrP) in BxPC-3 Protein and Increases Cancer Cell Motility.
    Yang L; Gao Z; Hu L; Wu G; Yang X; Zhang L; Zhu Y; Wong BS; Xin W; Sy MS; Li C
    J Biol Chem; 2016 Feb; 291(8):3905-17. PubMed ID: 26683373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice.
    Puig B; Altmeppen HC; Linsenmeier L; Chakroun K; Wegwitz F; Piontek UK; Tatzelt J; Bate C; Magnus T; Glatzel M
    PLoS Pathog; 2019 Jan; 15(1):e1007520. PubMed ID: 30608982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site.
    Haigh CL; Lewis VA; Vella LJ; Masters CL; Hill AF; Lawson VA; Collins SJ
    Cell Res; 2009 Sep; 19(9):1062-78. PubMed ID: 19597535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shedding light on prion disease.
    Glatzel M; Linsenmeier L; Dohler F; Krasemann S; Puig B; Altmeppen HC
    Prion; 2015; 9(4):244-56. PubMed ID: 26186508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of endogenous PrPC processing in neuronal and non-neuronal cell lines.
    Lewis V; Collins SJ
    Methods Mol Biol; 2008; 459():229-39. PubMed ID: 18576158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts.
    Walmsley AR; Watt NT; Taylor DR; Perera WS; Hooper NM
    Mol Cell Neurosci; 2009 Feb; 40(2):242-8. PubMed ID: 19056496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane topology influences N-glycosylation of the prion protein.
    Walmsley AR; Zeng F; Hooper NM
    EMBO J; 2001 Feb; 20(4):703-12. PubMed ID: 11179215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tethering the N-terminus of the prion protein compromises the cellular response to oxidative stress.
    Zeng F; Watt NT; Walmsley AR; Hooper NM
    J Neurochem; 2003 Feb; 84(3):480-90. PubMed ID: 12558968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.